Paragon Genomics is a company that develops and commercializes ultra-high multiplex polymerase chain reaction-based target enrichment solutions for next-generation sequencing (NGS). Its proprietary CleanPlex background-removing technology enables NGS customers to develop targeted sequencing assays. The company serves a range of sectors, including cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring.
|HQ||Hayward, CA, US||Map|
|Employees (est.) (Jun 2022)||23||(-4%)|
Paragon Genomics total Funding
Paragon Genomics latest funding size
Time since last funding
|5 years ago|
Paragon Genomics investors
|Wisemont Capital, HEDA Ventures, Cowin Venture, Cloudstone Venture, Fosun Industrial Co|
Paragon Genomics has 148 Twitter Followers. The number of followers has increased 1.4% month over month and increased 2% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Paragon Genomics founded?
Paragon Genomics was founded in 2015.
How many employees does Paragon Genomics have?
Paragon Genomics has 23 employees.
Who are Paragon Genomics competitors?
Competitors of Paragon Genomics include Sino Biological, Swift Biosciences and Geneticist.
Where is Paragon Genomics headquarters?
Paragon Genomics headquarters is located at 3521 Investment Blvd #1, Hayward.
Where are Paragon Genomics offices?
Paragon Genomics has an office in Hayward.
How many offices does Paragon Genomics have?
Paragon Genomics has 1 office.
Receive alerts for 300+ data fields across thousands of companies